Publication | Open Access
Pharmacological closure of the patent ductus arteriosus.
22
Citations
53
References
2003
Year
Fluid RestrictionVascular MalformationSurgeryPharmacotherapyAnatomyTranslational MedicineVascular SurgerySepsisPediatric SurgeryCardiologyVascular PharmacologyTherapeutic ControversyVascular BiologySick InfantPharmacological ClosurePatient SafetyAnesthesiaMedicinePaediatric MedicinePatent Ductus Arteriosus
Pharmacological closure by indomethacin is customary if symptoms of PDA are not controlled adequately with fluid restriction and diuretics. Its use, however, requires a comprehensive clinical assessment of all the vital perinatal factors and a vigilant monitoring of the sick infant. Prophylactic use of indomethacin is discouraged. The decision to use pharmacological versus surgical treatment or both should be individualized based on evidence-based research and clinician's own experience. Surgical ligation remains the primary mode of therapy in cases of pharmacological treatment failure or recurrence.
| Year | Citations | |
|---|---|---|
Page 1
Page 1